Monday, 30 March 2015

BioDelivery Sciences pain drug fails late: stage study

(Reuters) - BioDelivery Sciences International Inc said its pain drug failed to meet the main goal of a late-stage study, sending the drugmaker's shares down nearly 30 percent premarket.















via Reuters: Health News Read More Here..

No comments:

Post a Comment